| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| |

|
|
QUOTE THIS:
WHAT THE MEDIA HAS BEEN SAYING ABOUT DDRF
We're already getting press for our doctors' work.
Here are just some of the articles in national publications and
professional journals.
|
|
|
American Society for Gastrointestinal
Endoscopy annual conference GO 2009; GI Outlook; in Seattle Washington
August 2009 featured two Special Lectures by Dr. Lawrence B. Cohen
– “The Politics and Science of Sedation” and “Production
Pressure – Balancing Quality and Quantity”.
Read more...
|
|
|
SALIX PHARMACEUTICALS, INC. awarded
the Digestive Disease Research Foundation an unrestricted grant
which will be utilized for medical student education and an unspecified
clinical research manuscript preparation. Learn
more about Salix...
|
|
|
“PRODUCTION PRESSURE IN ENDOSCOPY:
BALANCING QUANTITY AND QUALITY; an edtiorial by Dr. Lawrence Cohen
was published in Gastroenterology 2008, the official journal of
the AGA Institute.
Read
more…
|
|
|
"ENDOSCOPIC SEDATION: PREPARING
FOR THE FUTURE. AN ISSUE OF GASTROINTESTINAL ENDOSCOPY CLINICS"
edited by Lawrence Cohen, M.D. and James Aisenberg, M.D. was published
in February 2009 by Elsevier.; This volume is a result of the conference
co- sponsored by DDRF, Mount Sinai Medical Center and the ACG in
2007. Read
more…
|

|
|
In Making Colonoscopies More Comfortable,
Drs. Cohen and Aisenberg were recognized as national leaders for
their research in improving patient comfort.
Read more...
|
 |
|
A ‘Fantastic Voyage’
into Your GI Tract
reported on work by Dr. Aisenberg using a pill-sized camera to view
the digestive tract. Read
more...
|

|
|
AGA INSTITUTE REVIEW OF ENDOSCOPIC
SEDATION
Read more...
|
 |
|
CLINICAL TRIAL: A DOSE-RESPONSE STUDY
OF FOSPROPOFOL DISODIUM FOR MODERATE SEDATION DURING COLONOSCOPY
Read more...
|
 |
|
ENTERYX IMPLANTATION FOR GERD: EXPANDED
MULTICENTER TRIAL RESULTS AND INTERIM POSTAPPROVAL FOLLOW-UP TO
24 MONTHS Read more...
|
 |
|
BOWEL PREPARATION FOR COLONOSCOPY:
MAXIMIZING EFFICACY, MINIMIZING RISK Read
more...
|
 |
|
PRIMARY PREVENTION OF ADVERSE GASTRODUODENAL
EFFECTS FROM SHORT-TERM USE OF NON-STEROIDINAL ANTI-INFLAMMATORY
DRUGS BY OMEPRAZOLE 20MG IN HEALTHY SUBJECTS Read
more... |
DDRF is a 501(c)(3) organization
|
|